Kumar M, Jha A, Goswami P, Srivastava R, Manjit M, Bharti K
Discov Nano. 2025; 20(1):30.
PMID: 39937325
PMC: 11822163.
DOI: 10.1186/s11671-025-04195-w.
Yuan Y, Lin Q, Feng H, Zhang Y, Lai X, Zhu M
Nat Commun. 2025; 16(1):1439.
PMID: 39920155
PMC: 11806101.
DOI: 10.1038/s41467-025-56768-z.
Moazzeni S, Kyker-Snowman K, Cohen R, Wang H, Li R, Shreiber D
Sci Rep. 2025; 15(1):4296.
PMID: 39905109
PMC: 11794589.
DOI: 10.1038/s41598-025-88537-9.
Rumberger Rivera L, Springer N, Bailey K, Patel J, Brett C, Barker E
Pediatr Res. 2025; .
PMID: 39893288
DOI: 10.1038/s41390-025-03847-y.
Suvac A, Ashton J, Bristow R
Nat Rev Cancer. 2025; 25(3):167-188.
PMID: 39875616
DOI: 10.1038/s41568-024-00781-9.
Long-Term Therapeutic Effects of Ac-DOTA-E[c(RGDfK)] Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma.
Yoshimoto M, Washiyama K, Ohnuki K, Doi A, Inokuchi M, Kojima M
Pharmaceutics. 2025; 17(1).
PMID: 39861661
PMC: 11768328.
DOI: 10.3390/pharmaceutics17010009.
Computational frameworks transform antagonism to synergy in optimizing combination therapies.
Chen J, Lin A, Jiang A, Qi C, Liu Z, Cheng Q
NPJ Digit Med. 2025; 8(1):44.
PMID: 39828791
PMC: 11743742.
DOI: 10.1038/s41746-025-01435-2.
Synergistic Effects of Mistletoe Lectin and Cisplatin on Triple-Negative Breast Cancer Cells: Insights from 2D and 3D In Vitro Models.
Lyu S, Meshesha S, Hong C
Int J Mol Sci. 2025; 26(1.
PMID: 39796221
PMC: 11719730.
DOI: 10.3390/ijms26010366.
Evaluation of the Cancer-Preventive Effect of Resveratrol-Loaded Nanoparticles on the Formation and Growth of In Vitro Lung Tumor Spheroids.
Torrico Guzman E, Gravely M, Meenach S
Pharmaceutics. 2025; 16(12).
PMID: 39771566
PMC: 11677875.
DOI: 10.3390/pharmaceutics16121588.
How Tumors Affect Hemodynamics: A Diffusion Study on the Zebrafish Transplantable Model of Medullary Thyroid Carcinoma by Selective Plane Illumination Microscopy.
Carra S, Gaudenzi G, Franceschetti G, Collini M, Sironi L, Bouzin M
Int J Mol Sci. 2025; 25(24.
PMID: 39769158
PMC: 11678154.
DOI: 10.3390/ijms252413392.
Precision tumor treatment utilizing bacteria: principles and future perspectives.
Liu Z, Wang L, Wu P, Yuan L
Appl Microbiol Biotechnol. 2025; 109(1):2.
PMID: 39754636
PMC: 11700060.
DOI: 10.1007/s00253-024-13378-x.
Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacy.
Cuiffo B, Maxwell M, Yan D, Guemiri R, Boone A, Bellet D
Front Immunol. 2024; 15:1501679.
PMID: 39697325
PMC: 11652358.
DOI: 10.3389/fimmu.2024.1501679.
Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?.
Pagliari G, Colonese F, Canova S, Abbate M, Sala L, Petrella F
Cancers (Basel). 2024; 16(23).
PMID: 39682081
PMC: 11639858.
DOI: 10.3390/cancers16233892.
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.
Valerie N, Sanjiv K, Mortusewicz O, Zhang S, Alam S, Pires M
Nat Commun. 2024; 15(1):10347.
PMID: 39643609
PMC: 11624193.
DOI: 10.1038/s41467-024-54415-7.
Oxygen/Nitric Oxide Dual-Releasing Nanozyme for Augmenting TMZ-Mediated Apoptosis and Necrosis.
Ma J, Qiu J, Wright G, Wang S
Mol Pharm. 2024; 22(1):168-180.
PMID: 39571173
PMC: 11707740.
DOI: 10.1021/acs.molpharmaceut.4c00817.
A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.
Naylon S, Richaud A, Zhao G, Bui L, Dufresne C, Wu C
RSC Chem Biol. 2024; .
PMID: 39552936
PMC: 11562385.
DOI: 10.1039/d4cb00174e.
PH-sensitive adriamycin hydrochloride and oxaliplatin dual-loaded microspheres synergistically enhance local injections effect of hepatocellular carcinoma.
Weng J, Wu S, Pan Y, Lai Y, Zhu J, Jin W
Mater Today Bio. 2024; 29:101311.
PMID: 39525396
PMC: 11550001.
DOI: 10.1016/j.mtbio.2024.101311.
Highly Multiplexed Tissue Imaging in Precision Oncology and Translational Cancer Research.
Bollhagen A, Bodenmiller B
Cancer Discov. 2024; 14(11):2071-2088.
PMID: 39485249
PMC: 11528208.
DOI: 10.1158/2159-8290.CD-23-1165.
Exploiting protein domain modularity to enable synthetic control of engineered cells.
Haikal Y, Blazeck J
Curr Opin Biomed Eng. 2024; 31.
PMID: 39430298
PMC: 11486415.
DOI: 10.1016/j.cobme.2024.100550.
Three-Dimensional Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research.
Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran D, Isidoro C
Int J Biol Sci. 2024; 20(13):5293-5311.
PMID: 39430243
PMC: 11488579.
DOI: 10.7150/ijbs.96469.